COMMUNIQUÉS West-GlobeNewswire

Yamo Pharmaceuticals Presents Results from Phase 2 Study of L1-79 in Adolescents and Young Adult Males with Autism Spectrum Disorder at INSAR 2019
14/05/2019
New York , May 14, 2019 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals, LLC , a clinical stage pharmaceutical company developing a novel therapy for autism spectrum disorder (ASD), announced the presentation of results from a [...]
resTORbio Appoints Lloyd Klickstein, M.D., Ph.D., as Chief Scientific Officer
14/05/2019
BOSTON, May 14, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related [...]
Medexus Pharmaceuticals Announces Normal Course Issuer Bid
14/05/2019
MONTREAL, Quebec, May 14, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company”) (TSXV: MDP, OTCQB: PDDPF) announced today it has submitted to the TSX Venture Exchange (the “ Exchange ”) a notice of its [...]
CinCor Pharma In-Licenses Aldosterone Synthase Inhibitor, CIN-107, and Closes $50 Million Series A Financing
14/05/2019
Financing led by Sofinnova Investments to advance CIN-107 through clinical proof-of-concept in two indications CINCINNATI, May 14, 2019 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) announced today that it has [...]
Uptick Newswire Hosts Marijuana Company of America, Inc. on The Stock Day Podcast to Discuss Its Expansion in the Cannabis Industry
14/05/2019
PHOENIX, May 14, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Marijuana Company of America, Inc. (MCOA)(“the Company”), a Company that specializes in the development of hemp-based products, as [...]
LogicBio Reports First Quarter 2019 Financial Results and Provides Business Updates
14/05/2019
CAMBRIDGE, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio or the Company), a genome editing company focused on developing medicines to durably treat rare diseases, today [...]
Abeona Therapeutics Treats First Patient in Second Cohort of Phase 1/2 Clinical Trial for ABO-101 in Sanfilippo Syndrome Type B (MPS IIIB)
14/05/2019
Interim data expected in the second half of 2019 NEW YORK and CLEVELAND, May 14, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that [...]
B. Braun Announces $1 Billion Investment to Alleviate IV Fluid Shortages in the U.S. Healthcare System
14/05/2019
Solutions for Life represents B. Braun’s commitment to expand capacity and help ensure supply of life-saving fluids for hospitals, outpatient settings, and other care institutions WASHINGTON and BETHLEHEM, Pa., May 14, [...]
TRHC’s Capstone Performance Systems Gains New Clients and Expands Services in 1Q19
14/05/2019
Technical assistance advising and Medicare risk adjustment services spur growth MOORESTOWN, N.J., May 14, 2019 (GLOBE NEWSWIRE) -- Capstone Performance Systems, a subsidiary of Tabula Rasa HealthCare, Inc . (TRHC) ( [...]
Regenera Announces Publication of RPh201 Phase 2a Study Data for the Treatment of NAION in the Journal of Neuro-Ophthalmology
14/05/2019
Publication Highlights Encouraging Evidence of RPh201’s Safety and Efficacy in NAION Patients Data Supportive of Company’s Ongoing Multicenter US-Based Phase 3 Trial NESS-ZIONA, Israel, May 14, 2019 (GLOBE NEWSWIRE) -- [...]
MediWound to Host First Quarter Financial Results Conference Call on May 21at 8:30 a.m. Eastern Time
14/05/2019
YAVNE, Israel, May 14, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today [...]
Inovalon’s Elastic Container Technology Providing Cloud Burst Capacity On Demand
14/05/2019
BOWIE, Md., May 14, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that its Elastic Container Technology (ECT ® ) is now [...]
Intensity Therapeutics to Present Data on Intratumoral Injection of INT230-6 at the Frontiers in Cancer Immunotherapy Symposium
14/05/2019
WESTPORT, Conn., May 14, 2019 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc. , a clinical-stage biotechnology company pioneering a novel, immune-based approach to treat solid tumor cancers through direct injection of [...]
ProMIS Neurosciences Announces First Quarter 2019 Results
14/05/2019
Company continues to show significant progress on developing highly selective antibodies targeting root cause of Alzheimer’s and Parkinson’s diseases and ALS TORONTO and CAMBRIDGE, Mass., May 14, 2019 (GLOBE NEWSWIRE [...]
Entasis Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update
14/05/2019
Transformative start to the year with the first Phase 3 trial underway and key additions to the leadership team WALTHAM, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a [...]
Myovant Sciences Announces Positive Phase 3 Results from LIBERTY 1 Study Evaluating Once Daily Relugolix Combination Therapy in Women with Uterine Fibroids
14/05/2019
- Phase 3 study met primary efficacy endpoint with highly statistically significant 73.4% response rate (p < 0.0001); women experienced, on average, an 84.3% reduction in menstrual blood loss - Achieved six key [...]
OpGen Completes Initial FDA 510(k) Submission for its Acuitas® AMR Gene Panel Test to Identify Presence of Antibiotic Resistance
14/05/2019
New molecular test designed to detect 47 antibiotic-resistance genes with high sensitivity and specificity in less than three hours, empowering healthcare facilities to make more informed infection control decisions [...]
Onconova Therapeutics, Inc. Reports Business Highlights and First Quarter 2019 Financial Results
14/05/2019
NEWTOWN, Pa., May 14, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) , a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat [...]
Myriad Genetics to Present Multiple Studies at the 2019 American Society of Clinical Oncology Annual Meeting
14/05/2019
SALT LAKE CITY, May 14, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in personalized medicine, today announced that it will present results from multiple studies at the 2019 American Society [...]

Pages